Unique Attack Method for New Antibiotic
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Researchers discovered manikomycin, a soil-derived peptide that attacks bacteria in a unique way to bypass existing antibiotic resistance.
Read MoreA short course of antibiotics was similarly effective to a longer course for patients hospitalized with community-acquired pneumonia (CAP).
Read MoreA new delivery system allows four standard tuberculosis medications to be inhaled directly into the respiratory tract, potentially reducing side effects and improving treatment adherence.
Read MorePenicillin allergy evaluation and subsequent delabeling reduces unnecessary alternative antibiotic use and is safe for pregnant patients, according to new research presented at AAAAI 2026.
Read MoreDrug allergy labels (DAL) are common and largely unevaluated in children with primary immunodeficiencies, which could lead to worse patient outcomes.
Read MoreThe American Thoracic Society has published a new clinical practice guideline (CPG) on pneumonia care, including guidance on lung ultrasound, antibiotics, and corticosteroid use.
Read MoreThe Penicillin Allergy Verification and Evaluation (PAVE) Act fights antimicrobial resistance and improves patient outcomes.
Read MoreBetween 2019 and 2023, NDM-CRE infections—which include pneumonia, bloodstream infections, urinary tract infections, and wound infections—surged by more than 460% in the United States.
Read MoreResearchers using green light to activate penicillin say controlling drug activity with light will allow precise and safe treatment of localized infections.
Read MoreLung cancer patients who received the antibiotic vancomycin prior to SBRT had significantly better outcomes than the patients who received SBRT alone.
Read MoreWith the help of artificial intelligence, snake, scorpion, and spider venom may be able to help fight antibiotic resistance.
Read MoreRepeated antibiotic use before age 2 is associated with a higher risk for asthma, food allergies and hay fever later in life.
Read MoreNew research indicates that postnatal antibiotic exposure, not associated with additional respiratory infections, is associated with childhood asthma.
Read MoreAn international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
Read MoreThe antibiotic shows promising antibacterial activity against common NTM strains, with favorable safety profiles, low resistance potential, and high oral bioavailability.
Read MoreCystic fibrosis patients with elevated levels of bacteria infected by Pf phage in their sputum experience a faster decline in lung function.
Read MoreResearchers are investigating how infant antibiotic use affects the airway and gut microbiome, which could inform interventions to reduce childhood asthma risk in children needing antibiotics in early life.
Read MoreTaking antibiotics when sick with the flu might actually backfire, making it more likely for patients to develop serious bacterial pneumonia instead of preventing it, Cedars-Sinai researchers found.
Read MorePneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read MoreChildren with pneumonia who were visited by medical clowns had shorter hospital stays and required fewer days of intravenous antibiotics.
Read MoreA new model shows that combining antibiotics with enzymes improved the removal of tough biofilms in VAP, a finding that could lead to more effective treatments.
Read MoreThe study aims to determine whether delayed antibiotics, compared to immediate prescribing, results in decreased antibiotic use and similar clinical improvement in children with mild pneumonia.
Read MoreMany children with recurrent wheezing have undetected lung infections that may be more effectively treated with antivirals instead of commonly prescribed steroids.
Read MoreThe study results confirm omadacycline as a safe and effective treatment for moderate to severe community-acquired bacterial pneumonia, demonstrating non-inferiority to moxifloxacin.
Read More